Trial
NCT03660930
Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
Aadi Bioscience, Inc.
Condition
Advanced Soft Tissue Sarcoma
Intervention
Sirolimus Albumin-bound Nanoparticles
Why stopped
Study was terminated at completion of the Phase 1 dose escalation due to loss of financial support.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-04-30